Posted by Michael Wonder on 27 Apr 2022
PHARMAC welcomes analysis into cancer medicines in Aotearoa
28 April 2022 - PHARMAC welcomes a new report released today by Te Aho o Te Kahu (the Cancer Control Agency) which analyses the access and efficacy of cancer medicines for solid tumours in adult patients in Aotearoa.
The new analysis, Understanding the gap: an analysis of the availability of cancer medicines in Aotearoa, found twenty gaps (18 individual medicines across ten types of cancer) where medicines funded in Australia would offer clinical benefit to New Zealanders.
